|
BE615511A
(https=)
|
1961-03-25 |
|
|
|
|
NL292958A
(https=)
|
1962-05-29 |
1900-01-01 |
|
|
|
GB8809205D0
(en)
|
1988-04-19 |
1988-05-25 |
Nye P C G |
Treatment of oedema
|
|
US5137871A
(en)
|
1989-07-28 |
1992-08-11 |
Regents Of The University Of California |
Treatment to reduce edema for brain and musculature injuries
|
|
DE4010536A1
(de)
*
|
1990-04-02 |
1991-10-10 |
Boehringer Mannheim Gmbh |
Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure
|
|
DE4113820A1
(de)
|
1991-04-27 |
1992-10-29 |
Boehringer Mannheim Gmbh |
Verwendung von torasemid zur behandlung von hirnoedemen
|
|
US5486530A
(en)
|
1991-04-27 |
1996-01-23 |
Boehringer Mannheim Gmbh |
Use of torasemide for the treatment of brain oedemas
|
|
US5858702A
(en)
|
1991-12-13 |
1999-01-12 |
The Johns Hopkins University |
Isolation, cloning and expression of transmembrane water channel Aquaporin 5 (AQP5)
|
|
US5741671A
(en)
|
1991-12-12 |
1998-04-21 |
The Johns Hopkins University |
Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1)
|
|
US5519035A
(en)
|
1993-07-02 |
1996-05-21 |
Cornell Research Foundation, Inc. |
Treatment of stroke or in anticipation of the occurrence of brain ischemia
|
|
US20060167110A1
(en)
|
1995-01-13 |
2006-07-27 |
Blume Cherly D |
Methods for treating cerebrovascular disease by administering desmethylselegiline
|
|
CA2243643A1
(en)
|
1996-11-18 |
1998-05-28 |
Susan Haas |
Methods and compositions for inducing oral tolerance in mammals
|
|
WO1999007382A1
(en)
|
1997-08-06 |
1999-02-18 |
Smithkline Beecham Corporation |
Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
|
|
US5905090A
(en)
|
1998-04-29 |
1999-05-18 |
Italfarmaco S.P.A. |
Analogues of the active metabolite of leflunomide
|
|
CO5180581A1
(es)
*
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
|
US6500809B1
(en)
|
1999-11-12 |
2002-12-31 |
Neuron Therapeutics, Inc. |
Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
|
|
EP1106614B1
(en)
|
1999-12-10 |
2004-01-07 |
Pfizer Inc. |
5-Membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
|
|
KR20090090406A
(ko)
|
2000-12-18 |
2009-08-25 |
가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 |
염증성 사이토카인 생산 유리 억제제
|
|
US8980952B2
(en)
|
2002-03-20 |
2015-03-17 |
University Of Maryland, Baltimore |
Methods for treating brain swelling with a compound that blocks a non-selective cation channel
|
|
EP2438913B1
(en)
|
2002-03-20 |
2020-05-06 |
University of Maryland, Baltimore |
A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling
|
|
WO2003103658A1
(ja)
|
2002-06-05 |
2003-12-18 |
株式会社医薬分子設計研究所 |
免疫関連プロテインキナーゼ阻害剤
|
|
WO2003103648A1
(ja)
|
2002-06-05 |
2003-12-18 |
株式会社医薬分子設計研究所 |
糖尿病治療薬
|
|
EP1512396A4
(en)
|
2002-06-05 |
2008-12-31 |
Inst Med Molecular Design Inc |
HEMMER AGAINST ACTIVATION OF AP-1 AND NFAT
|
|
JP4743382B2
(ja)
*
|
2002-06-06 |
2011-08-10 |
株式会社医薬分子設計研究所 |
Ｏ−置換ヒドロキシアリール誘導体
|
|
CA2488367A1
(en)
|
2002-06-06 |
2003-12-18 |
Institute Of Medicinal Molecular Design, Inc. |
Antiallergic agents
|
|
EA010835B1
(ru)
|
2002-06-10 |
2008-12-30 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
Лекарственное средство для лечения рака
|
|
EP1535609A4
(en)
|
2002-06-10 |
2009-01-07 |
Inst Med Molecular Design Inc |
Nf-kb activation inhibitors
|
|
CA2488979A1
(en)
|
2002-06-11 |
2003-12-18 |
Institute Of Medicinal Molecular Design, Inc. |
Medicament for treatment of neurodegenerative diseases
|
|
KR20050029209A
(ko)
|
2002-07-15 |
2005-03-24 |
미리어드 제네틱스, 인크. |
화합물, 조성물 및 이의 사용방법
|
|
WO2004068928A2
(en)
|
2003-02-06 |
2004-08-19 |
Uutech Limited |
Bradykinin b2 receptor antagonist peptide from amphibian skin
|
|
EA010948B1
(ru)
|
2003-05-01 |
2008-12-30 |
Инноджен Калбиотех Пте Лтд. |
Фармацевтическая композиция, содержащая лактат, и ее применение
|
|
RU2006104697A
(ru)
|
2003-07-16 |
2006-06-27 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. (Jp) |
Лекарственное средство для лечения пигментации кожи
|
|
EP1680411A2
(en)
|
2003-10-08 |
2006-07-19 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
|
|
US8467876B2
(en)
|
2003-10-15 |
2013-06-18 |
Rmx, Llc |
Breathing disorder detection and therapy delivery device and method
|
|
WO2005039556A1
(ja)
|
2003-10-29 |
2005-05-06 |
Institute Of Medicinal Molecular Design. Inc. |
血行再建術後の再狭窄又は再閉塞の治療及び／又は予防のための医薬
|
|
JP2007512845A
(ja)
|
2003-12-02 |
2007-05-24 |
アネシバ・インコーポレイテッド |
Ｎｆ−κｂオリゴヌクレオチドデコイ分子
|
|
AU2005287090A1
(en)
|
2004-09-18 |
2006-03-30 |
Department Of Veterans Affairs |
Therapeutic agents targeting the NCca-ATP channel and methods of use thereof
|
|
JP5307397B2
(ja)
|
2004-09-18 |
2013-10-02 |
ユニバーシティ オブ メリーランド，ボルチモア |
ＮＣＣａ−ＡＴＰチャネルを標的とする治療剤およびその使用方法
|
|
US7601745B2
(en)
|
2004-09-27 |
2009-10-13 |
4Sc Ag |
Heterocyclic NF-kB inhibitors
|
|
KR20070111475A
(ko)
|
2005-01-04 |
2007-11-21 |
노파르티스 아게 |
만성 변비 환자에서 테가세로드의 효능을 확인하기 위한바이오마커
|
|
TWI462745B
(zh)
|
2005-04-28 |
2014-12-01 |
Takeda Pharmaceutical |
安定的乳化組成物
|
|
WO2007084464A2
(en)
|
2006-01-17 |
2007-07-26 |
The University Of North Carolina At Chapel Hill |
Water channel blockers and methods of use thereof
|
|
JP4273235B2
(ja)
|
2006-06-01 |
2009-06-03 |
国立大学法人 新潟大学 |
アクアポリン４阻害薬
|
|
KR20090016762A
(ko)
|
2006-06-06 |
2009-02-17 |
제넨테크, 인크. |
혈관 발달을 조정하기 위한 조성물 및 방법
|
|
KR20090027227A
(ko)
|
2006-06-06 |
2009-03-16 |
제넨테크, 인크. |
항-ｄｌｌ4 항체 및 이의 사용 방법
|
|
US7671058B2
(en)
|
2006-06-21 |
2010-03-02 |
Institute Of Medicinal Molecular Design, Inc. |
N-(3,4-disubstituted phenyl) salicylamide derivatives
|
|
WO2008046014A1
(en)
|
2006-10-12 |
2008-04-17 |
Remedy Pharmaceuticals, Inc. |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective ca++- activated atp-sensitive cation channels regulated by sur1 receptors
|
|
US10004703B2
(en)
|
2006-10-12 |
2018-06-26 |
Biogen Chesapeake Llc |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels
|
|
JP2010508300A
(ja)
|
2006-10-26 |
2010-03-18 |
フライン、ギャリー・エー． |
アクアポリン修飾因子並びに浮腫および体液平衡異常の治療のためのそれらの使用方法
|
|
US9316633B2
(en)
*
|
2006-11-16 |
2016-04-19 |
The Regents Of The University Of California |
Methods for identifying inhibitors of solute transporters
|
|
US20080171719A1
(en)
|
2006-11-28 |
2008-07-17 |
Alcon Manufacturing, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
WO2008067382A2
(en)
|
2006-11-28 |
2008-06-05 |
Alcon Research, Ltd. |
Rnai-mediated inhibition of aquaporin 4 for treatment of iop-related conditions
|
|
US9511075B2
(en)
|
2007-01-12 |
2016-12-06 |
The University Of Maryland, Baltimore |
Targeting NCCA-ATP channel for organ protection following ischemic episode
|
|
US20120183600A1
(en)
*
|
2007-01-16 |
2012-07-19 |
Chien-Hung Chen |
Novel composition for treating metabolic syndrome and other conditions
|
|
CA2675638C
(en)
|
2007-01-16 |
2015-11-24 |
Ipintl, Llc |
Composition comprising serotonin for treating metabolic syndrome
|
|
WO2008098160A1
(en)
|
2007-02-09 |
2008-08-14 |
University Of Maryland, Baltimore |
Antagonists of a non-selective cation channel in neural cells
|
|
AU2008216612B2
(en)
|
2007-02-17 |
2014-12-04 |
President And Fellows Of Harvard College |
Compositions and method for tissue preservation
|
|
TW200848063A
(en)
|
2007-04-23 |
2008-12-16 |
Combinatorx Inc |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
WO2009002832A2
(en)
|
2007-06-22 |
2008-12-31 |
University Of Maryland, Baltimore |
Inhibitors of ncca-atp channels for therapy
|
|
WO2009006555A2
(en)
|
2007-07-02 |
2009-01-08 |
Yu, Ming |
Methods, composition, targets for combinational cancer treatments
|
|
CN101842093B
(zh)
|
2007-10-23 |
2012-08-22 |
株式会社医药分子设计研究所 |
Pai-1产生抑制剂
|
|
US20090239868A1
(en)
|
2007-10-23 |
2009-09-24 |
Institute Of Medical Molecular Design, Inc. |
Inhibitor of pai-1 production
|
|
PT2868315T
(pt)
|
2007-12-04 |
2017-09-04 |
Remedy Pharmaceuticals Inc |
Formulações melhoradas e métodos para liofilização e liofilizados assim produzidos
|
|
GB0724340D0
(en)
|
2007-12-13 |
2008-01-30 |
Univ Dundee |
Novel Therapeutic Agents
|
|
CA2709784A1
(en)
*
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US20110034560A1
(en)
|
2008-01-29 |
2011-02-10 |
Sven Jacobson |
Liquid formulations of compounds active at sulfonylurea receptors
|
|
US8211882B2
(en)
|
2008-03-08 |
2012-07-03 |
Richard Delarey Wood |
Glutamate receptor modulators and therapeutic agents
|
|
WO2009139925A1
(en)
|
2008-05-16 |
2009-11-19 |
Panacea Pharmaceuticals, Inc. |
Methods for the treatment of brain edema
|
|
US20110263478A1
(en)
|
2008-09-16 |
2011-10-27 |
Simard J Marc |
Sur1 inhibitors for therapy
|
|
WO2010048273A2
(en)
|
2008-10-21 |
2010-04-29 |
President And Fellows Of Harvard College |
Methods and compounds for treatment of neurodegenerative disorders
|
|
GB0823366D0
(en)
|
2008-12-22 |
2009-01-28 |
Uni I Oslo |
Synthesis
|
|
JP5778583B2
(ja)
|
2009-01-12 |
2015-09-16 |
バギ リサーチ リミテッド |
炎症を治療するためおよび免疫応答を調節するための化合物ならびにそれらの使用
|
|
WO2010096627A1
(en)
|
2009-02-20 |
2010-08-26 |
Lisanti Michael P |
Therapeutics and methods for treating neoplastic diseases comprising determining the level of caveolin-1 and/or caveolin-2 in a stromal cell sample
|
|
BR112012022654A2
(pt)
|
2010-03-10 |
2016-11-01 |
Univ Florida |
modulação de aquaporinas com relaxina
|
|
EP3339190A1
(en)
|
2010-07-19 |
2018-06-27 |
Biogen Chesapeake LLC |
Containers for glyburide solutions
|
|
EP2598145A1
(en)
*
|
2010-07-28 |
2013-06-05 |
Boehringer Ingelheim International GmbH |
Pharmaceutical composition for treatment of respiratory and inflammatory diseases
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
US20120238623A1
(en)
|
2011-03-14 |
2012-09-20 |
Chandraratna Roshantha A |
Inflammation and Autoimmune Disorder Treatment using RARa Selective Agonists
|
|
SI2717883T1
(sl)
*
|
2011-05-02 |
2017-06-30 |
Stichting Vumc |
Zaščita pred motnjo endotelijske pregrade z inhibicijo tirozin kinaze ABL-sorodnega gena (ARG)
|
|
RU2461375C1
(ru)
*
|
2011-05-19 |
2012-09-20 |
Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) |
Способ комбинированного лечения больных местно-распространенным раком желудка
|
|
WO2013152313A1
(en)
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
WO2013165606A1
(en)
|
2012-05-04 |
2013-11-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modulators of the relaxin receptor 1
|
|
JP6238969B2
(ja)
*
|
2012-05-08 |
2017-11-29 |
エアロミクス・インコーポレイテッドＡｅｒｏｍｉｃｓ，Ｉｎｃ． |
新規方法
|
|
CN105636583B
(zh)
|
2013-09-13 |
2019-08-20 |
板井昭子 |
水溶液制剂及其制造方法
|
|
WO2015069956A2
(en)
|
2013-11-06 |
2015-05-14 |
Aeromics, Llc |
Novel formulations
|
|
LT3080134T
(lt)
|
2013-12-13 |
2018-11-12 |
Vertex Pharmaceuticals Incorporated |
Piridono amidų provaistai, naudotini kaip natrio kanalų moduliatoriai
|
|
JP2017535546A
(ja)
|
2014-11-13 |
2017-11-30 |
エアロミクス・インコーポレイテッドＡｅｒｏｍｉｃｓ，Ｉｎｃ． |
新規な方法
|
|
MX384247B
(es)
|
2015-05-29 |
2025-03-14 |
Univ Maryland |
Antagonistas del sur1- trpm4 para usarse para reducir o prevenir daño a la íntima provocado por estimulación mecánica de células endoteliales.
|
|
CA3001321A1
(en)
|
2015-10-07 |
2017-04-13 |
Biogen Chesapeake Llc |
Methods of treating injuries or conditions related to cns edema
|
|
CA3022684A1
(en)
|
2016-05-13 |
2017-11-16 |
Aeromics, Inc. |
Crystals
|
|
JP7165648B2
(ja)
|
2016-07-29 |
2022-11-04 |
バイオジェン チェサピーク エルエルシー |
Ｓｕｒ１－ｔｒｐｍ４チャネル阻害剤による医療処置方法
|
|
US20230293556A1
(en)
*
|
2020-08-05 |
2023-09-21 |
Jiangsu Simcere Pharmaceutical Co., Ltd. |
Pharmaceutical composition of aquaporin inhibitor and preparation method thereof
|